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ABSTRACT 
Although RNA-Seq data provide unprecedented isoform-level expression information, detection of 
alternative isoform regulation (AIR) remains difficult, particularly when working with an incomplete 
transcript annotation. We introduce JunctionSeq, a new method that builds on the statistical techniques 
used by the well-established DEXSeq package to detect differential usage of both exonic regions and 
splice junctions. In particular, JunctionSeq is capable of detecting differentials in novel splice junctions 
without the need for an additional isoform assembly step, greatly improving performance when the 
available transcript annotation is flawed or incomplete. JunctionSeq also provides a powerful and 
streamlined visualization toolset that allows bioinformaticians to quickly and intuitively interpret their 
results. We tested our method on publicly available data from several experiments performed on the rat 
pineal gland and Toxoplasma gondii, successfully detecting known and previously validated AIR genes in 
19 out of 19 gene-level hypothesis tests. Due to its ability to query novel splice sites, JunctionSeq is still 
able to detect these differentials even when all alternative isoforms for these genes were not included in 
the transcript annotation. JunctionSeq thus provides a powerful method for detecting alternative isoform 
regulation even with low-quality annotations. An implementation of JunctionSeq is available as an 
R/Bioconductor package. 
 
 INTRODUCTION 
In 2015 alone, hundreds of research papers have reported differential gene expression (DGE) based 
on RNA-Seq data (1-10). In general, RNA-Seq studies focus primarily on detecting gene-wide effects, in 
which entire genes are upregulated or downregulated depending on some experimental or biological 
condition. Although the statistical methodologies have advanced considerably, these studies generally 
follow the same basic design principles as previous microarray-based expression research.  
However, RNA-Seq data provide more than simple measurements of gene-level expression. In theory, 
RNA-Seq can be used to study more complex regulatory phenomena at the isoform level, even when the 
isoforms in question are unannotated. Numerous tools have been developed to detect alternative isoform 
regulation (AIR) (11); however, only a few of these tools have seen serious application outside their 
respective methodology papers, and many RNA-Seq studies do not even attempt the detection of AIR 
(12-14). 
Detecting alternative isoform regulation is inherently difficult in RNA-Seq, as sequencer reads are 
often one or more orders of magnitude shorter than the transcripts themselves. While there are several 
utilities that attempt to de-convolute read data into isoform abundances, the accuracy and robustness of 
these methods is difficult to establish (15,16). Isoform expression estimates seem to vary considerably 
between different tools, and generally depend on the quality and completeness of the transcript assembly 
(17,18). Most of the newest and most popular tools do not assess or model unannotated isoforms 
(including Kallisto (19), eXpress (20), and RSEM (21)), and the presence of such isoforms can 
substantially alter the estimated abundances of the known isoforms belonging to a gene. Thus: accurate 
analysis of differential isoform regulation may be very difficult when the available transcript annotation is 
incomplete.  
In addition, almost all existing AIR analysis tools share one common flaw: the results are difficult to 
interpret. This is not a trivial issue: unlike simple DGE, instances of AIR cannot be adequately 
characterized by a single fold change and p-value. Alternative isoform regulation is a broad and diverse 
class of phenomena that can involve alternative splice sites, alternative promoters, nucleosome 
occupancy, cassette exons, alternative donors/acceptors, long non coding RNAs, alternative 
polyadenylation, gene-level differential expression, or any number of these factors in combination. A 
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gene may be composed of dozens of distinct isoforms, each controlled by its own set of regulatory 
mechanisms. As a consequence, the raw results of alternative isoform regulation analyses are often 
counterintuitive and resistant to interpretation.  
The interpretation of these results is critical: in order to be considered credible by the community, any 
detected instances of AIR will generally require validation by secondary methods (such as qRT-PCR or 
SMRT sequencing). Such validation is often costly and time consuming. Detecting the mere presence of 
an effect is insufficient for these purposes: the investigator must also be able to identify which specific 
isoforms are being differentially used and assess the strength, direction, and credibility of the effect. 
Furthermore: since hundreds of AIR genes may be detected, this interpretation process must be 
streamlined, scalable, and intuitive. 
The DEXSeq software package tests for differential usage of exonic regions as a proxy for differential 
isoform usage, and provides a powerful suite of visualization tools (22,23). However, DEXSeq is only 
effective at detecting AIR when it results in changes in the expression of the annotated exonic regions. 
This method has two major weaknesses: firstly, it does not query all forms of alternative isoform 
regulation, as not all forms of AIR necessarily produce differentials in the exon counts. Secondly, this 
method is strongly dependent on the reference annotation, and cannot directly identify differentials in 
novel exons and splice junctions. Additionally, DEXSeq output plots are often difficult to read and 
interpret, particularly for genes with a large number of isoforms and splice variants. 
Here, we introduce JunctionSeq, a new method and associated Bioconductor package that builds upon 
the popular and well-established DEXSeq methodology in order to detect differential usage of both exons 
and known or novel splice junctions. Unlike most similar tools, JunctionSeq can reliably detect alternative 
isoform regulation even when the alternatively regulated isoforms themselves are not annotated. 
JunctionSeq also provides improved visualization tools that produce readable and informative expression 
profiles across all potential genes of interest, and across the genome as a whole.  
METHODS 
Differential Usage 
Estimating the true isoform abundance of overlapping multi-kb transcripts using hundred-base-pair 
reads is an inherently difficult and error-prone task, particularly when some of the isoforms are not known 
a priori. Rather than attempting to directly estimate these isoform abundances, we instead attempt to 
detect differentials in quantities that are directly observable: the read counts for exonic regions and splice 
junction loci. Since all major aligners designed for RNA-Seq will align across novel (unannotated) splice 
junctions (24), we can also test for differential usage of these novel splicing variants. 
“Differential usage” (DU) is an observed phenomenon in which individual transcript sub-components 
(in this case, exons or splice junctions) display expression that is inconsistent with that of the gene as a 
whole. This can sometimes be counterintuitive: if a gene is differentially expressed, an individual sub-
component that displays constant expression across all samples might be considered “differentially used”, 
as its expression is not consistent with that of the gene. 
Testing for differential usage of splice junctions has a number of benefits. Firstly, since splice events 
are discrete and identifiable we can include novel splicing variants when they splice to/from known 
genes. This allows us to indirectly query for differential regulation in unknown isoforms, improving 
performance on sparsely annotated genomes. Furthermore, some forms of AIR do not necessarily result in 
observable differentials in the exon-level counts. An intron retention, for example, will alter splice 
junction counts but not the counts of the flanking exons. As a result, our method substantially broadens 
the variety of regulatory phenomena that can be effectively detected. 
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Statistical Methodology 
Like the DEXSeq Bioconductor package, we first partition each gene into a set of mutually non-
overlapping exonic regions, and then use the read (or read-pair) counts for each exonic region to estimate 
the relative expression of each exon for each experimental condition (22). Unlike the DEXSeq package, 
we also calculate counts for each splice junction belonging to each gene, including novel splice junctions 
that are within the gene’s span that surpass a user-specified normalized mean coverage threshold (we 
recommend 3 reads per sample). We use the DESeq2 package along with a set of specialized multivariate 
generalized linear models (GLM) to individually test for differential usage of each exonic region and 
splice junction (23).  
Previous studies have done similar analyses simply by plugging splice junction counts into DEXSeq 
(25), however we found this method to be inadequate as it did not account for the numerous differences in 
the distribution and structure of the splice junction count data. A number of modifications to the basic 
DEXSeq methodology were found to be necessary.  
To begin with: for most datasets DEXSeq will double- or triple-counts the vast majority of reads, as it 
uses the sum of all exonic regions as a proxy for estimating gene-level expression. This would be even 
more pronounced in JunctionSeq, and while it would not technically invalidate the hypothesis tests it can 
bias the fold-change estimates by over-weighting variant-dense regions, producing confusing artifacts 
under certain conditions. Thus, we use gene-level counts as the basis for our estimates of gene-wide 
expression rather than the sum of all exonic regions. This means that in the JunctionSeq framework no 
read or read-pair is counted more than once in any given statistical model. This model framework was 
applied to both the hypothesis test and the effect estimation steps. For similar reasons, our size factor 
estimation is carried out using the gene-level counts rather than the exon/junction counts. 
In addition, we found that splice junctions and exonic regions sometimes followed different 
dispersion trends from one another. This is not surprising, given the various biological and technical 
differences between the two count types. To account for this difference, JunctionSeq (by default) fits 
separate dispersion trends for exonic regions and for splice junctions. As in DEXSeq, the final dispersion 
estimates used for hypothesis testing are calculating by estimating the maximum a priori (MAP) 
dispersions for each exon and junction, which “shrinks” each feature-specific dispersion estimate towards 
its respective fitted dispersion estimate (23). 
For a complete description of the JunctionSeq methodology, see Section 3 of the online supplement. 
The Interpretation Problem 
Most existing AIR utilities provide little-to-no functionality to assist the end-user in the interpretation 
of the results. Some tools provide basic analysis-wide summary plots (22,26,27) or expression profile 
plots for individual samples (13,27-32), but very few provide methods for directly comparing gene 
expression profiles between multi-sample experimental groups. Many tools provide little information to 
the user beyond p-values and fold changes (11). 
The DEXSeq visualization toolset, while unparalleled in its class, was found to be insufficient for our 
purposes (22). DEXSeq generates a number of gene profile plots that show read/read-pair coverage across 
each exonic region, plotted above a representation of the isoform annotation (see Figure 2b). However, 
genes vary widely in the number of exons and isoforms they possess, and as a result these plots vary 
widely in the complexity of the data they present. Consequently: regardless of the specific graphical 
settings, DEXSeq-generated plots often suffer from over-plotting, severely reducing their utility. 
JunctionSeq implements a number of refinements designed to streamline and improve this process. 
Many parameters are automatically adjusted for each figure to improve readability, including adjustments 
to the feature label size and orientation, figure aspect ratio, relative size of the left and right panels, y-axis 
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scaling, figure margins, and label positioning (See Figure 1, Figure 2, and Figure 4). Other improvements 
were added to make the plots more informative, including the nonlinear expansion of small features, 
highlighting of significant features, nested splice junction diagrams, and the inclusion of a gene-level 
expression plot. The various plots can either be viewed manually or browsed using a set of automatically-
generated html pages, designed for easy navigation between genes and between experiments. 
While these features might seem cosmetic, they vastly improve the utility and scalability of this tool 
and allow investigators to quickly examine a large number of potential genes of interest in order to 
identify, characterize, and assess interesting biological phenomena.  
The JunctionSeq analysis pipeline also generates genome-wide browser tracks suitable for use with 
IGV or the UCSC genome browser (See Figure 3). These tracks allow investigators to interactively 
browse expression profiles, splice junction counts, and statistically significant features across the entire 
genome, all alongside the numerous publicly available annotation tracks (32,33). 
RESULTS 
To demonstrate the strengths of our new method, we applied JunctionSeq to two different publicly 
available datasets. The first was in Toxoplasma gondii and included 3 analyses; the second was in rat 
pineal glands and included 4 analyses. Both datasets included known and validated AIR genes, one gene 
in the Toxoplasma gondii dataset and four genes in the rat pineal gland dataset.  Thus, there were a total 
of 19 gene-level hypothesis tests in which we expected to detect differential usage, acting as positive 
controls in our analysis. 
JunctionSeq consistently detected differential usage in all known AIR genes across all experiments, 
even when the alternative isoforms were not included in the transcript annotation. 
Test dataset 1: Toxoplasma gondii and TgSR3  
Our first test dataset originated from a previous study in which alternative splicing was detected and 
validated in Toxoplasma gondii between control samples and samples in which overexpression of the 
TgSR3 gene was induced (34). There were four sample groups of 3 biological replicates each: untreated; 
induced, 4 hours; induced, 8 hours; and induced, 24 hours. The dataset is available from the NCBI short 
read archive (SRA), accession number PRJNA252680. 
In the original study numerous genes were found to display differential splicing between the induced 
and untreated sample groups. One particular gene, TGGT1_207900, was found to display strong 
differential splicing across an unannotated 5’ variant in all three comparisons. This effect was detected 
using DEXSeq via a CuffLinks assembly, and was subsequently confirmed via qRT-PCR. In order to 
demonstrate JunctionSeq’s ability to detect differential usage of novel variants, we performed the same 
analysis using JunctionSeq, but without the benefit of the CuffLinks assembly step.  
Detection of AIR without CuffLinks assembly: 
Even without a complete transcript assembly, JunctionSeq detected differential usage of the 
previously-validated novel splice variant in TGGT1_207900 in all three experiments, with adjusted p-
values of 0.00023, 8.5x10-13, and 0.0098 for the untreated vs 4-hour, 8-hour, and 24-hour experiments, 
respectively. The gene profile plots clearly displayed the same form of differential splicing found in the 
original experiment (see Figure 1 and Supplemental figs. 1-2) (34).  
This demonstrates that JunctionSeq can accurately detect differentials in novel splicing variants, and 
does not require a complete and comprehensive transcript annotation in order to detect alternative isoform 
regulation. 
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Test dataset 2: Circadian Rhythms in the Rat Pineal Gland 
The rat pineal gland is known to display strong and consistent differential expression resulting from 
neural stimulation across hundreds or thousands of genes (35,36). Most if not all of these changes are 
believed to be controlled via neural innervation of the pineal gland by the SCG, using the 
neurotransmitter norepinephrine (NE) and the second messenger cyclic AMP (cAMP) (37-44). 
Several genes have already been found in the literature to exhibit neurally-controlled alternative 
isoform usage in the rat pineal gland: Crem (45-47), Pde4b (48), Atp7b (49), and Slc15a1 (formerly 
known as Pept1) (50,51). It should be noted that all of these genes were discovered in previous studies 
using different datasets, and all are validated and well-established in the literature. 
We performed four comparisons in which we expected to detect differential splicing in genes that are 
neurally controlled by norepinephrine and cAMP: two in vivo analyses comparing night and day 
conditions in no-surgery (Ctrl) and sham-surgery (Sham) rats, as well as two in vitro analyses comparing 
pineal glands in organ culture that had been treated with norepinephrine (NE) or dibutyryl cyclic AMP 
(DBcAMP, an analogue of the second messenger, cyclic AMP), each versus an untreated control set 
(CN). Given that the four known-AIR genes are neurally controlled, we expect to detect differential usage 
in all four genes across all four comparisons. 
Detection of Known AIR genes: 
For the four known AIR genes, we found strong genome-wide statistical significance for all 16 gene-
level hypothesis tests (see Table 2). The genes Crem, Pde4b, and Atp7b were detected by JunctionSeq at 
an extremely high significance level in all analyses (p-adjust < 1e-8 for all three genes and all four 
comparisons), and the gene Slc15a1 was detected at a moderately high significance level in all analyses 
(p-adjust < 0.01). See Figure 2a for an example plot displaying the JunctionSeq results for the Crem gene 
in the sham-surgery group. 
Differential usage of novel variants 
To demonstrate JunctionSeq’s ability to detect differential usage of novel splice junctions even with 
an incomplete transcript assembly, we performed a second set of analyses with a reduced annotation. For 
each of the three known AIR genes that had multiple annotated transcripts (Crem, Pde4b, and Atp7b), we 
manually removed all but one transcript from the ensembl annotation GTF and then re-ran the analyses. 
This was intended to simulate the scenario in which AIR occurs in poorly-annotated genes. The gene 
Slc15a1 only has one transcript in the current annotation, and thus the annotation was left unchanged. 
Even with only one annotated transcript, JunctionSeq was still able to detect differential usage of 
“novel” splice sites for all four genes across all four comparisons (p-adjust < 0.01, see the right half of 
Table 2). See Figure 4a for an example plot displaying the incomplete-annotation JunctionSeq results for 
the Crem gene in the sham-surgery group. 
Replicability and consistency: 
In addition to confirming known AIR genes and providing a strong positive control for JunctionSeq, 
we can further use these analyses to demonstrate the reliability and replicability of our methods by 
examining the overlap between the four comparisons. 
While these experiments are not direct replications, isoforms whose regulation is controlled 
specifically by neural innervation of the pineal gland through the SCG (via norepinephrine and cyclic 
AMP) should theoretically exhibit similar expression regulation across all four experiments. 
In each comparison hundreds of genes were found to display statistically significant differential exon 
or splice-junction usage (at p-adjust < 0.01), and 42 of these genes displayed differential usage in all four 
analyses (see Table 1 and Supplemental fig. 3). The strong concordance between the four experiments 
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spanning very different (but biologically related) experimental conditions demonstrates that JunctionSeq 
produces consistent and replicable results. 
Comparison with Existing Tools 
Comparisons between differential isoform regulation tools are difficult, as many are actually designed 
to detect subtly distinct phenomena. As a consequence: even if both tools perform with perfect accuracy 
they may still return different results. CuffDiff, for example, performs alternative isoform regulation 
analysis that segregates genes by promoter site, excluding detection of differential alternative promotor 
usage. This would exclude all five of the previously-validated cases of alternative isoform usage found in 
our test datasets. Other transcript-alignment-based tools like Kallisto/Sleuth (19), eXpress (20), and RSEM 
(21) only detect overall differential expression of individual transcripts and do not attempt to detect 
differential usage of transcripts relative to one another. Thus, results from these tools would likely consist 
predominantly of differentially expressed genes, and would not specifically target differential splicing. 
Furthermore, most such tools are strongly annotation-dependent and do not attempt to assess novel splice 
variants. 
The obvious comparison, however, is with the DEXSeq software tool (22). We found that when the 
affected isoforms are known, JunctionSeq appears to perform at least as well (or better) than DEXSeq. 
However, when unannotated isoforms are involved JunctionSeq demonstrates clear superiority due to its 
ability to query unannotated splice junctions. 
Toxoplasma gondii analyses 
Without a CuffLinks assembly, DEXSeq was unable to detect any differential usage in the validated 
gene (TGGT1_207900) in any of the three Toxoplasma gondii analyses (see Figure 1b and Supplemental 
figures 1b and 2b). JunctionSeq, however, detects the differential usage of the alternative start site in all 
three analyses, even without the CuffLinks assembly. 
Rat pineal gland analyses 
In the rat pineal gland data, JunctionSeq and DEXSeq seemed to perform similarly when the full 
transcript annotation was used (see Table 1, Supplementary Table 1, and Supplementary Figures 3-4). 
Across all experiments JunctionSeq detected at least as many statistically significant genes in each 
experiment individually and found more genes that overlapped between all four analyses. 
For the four known-AIR genes, DEXSeq and JunctionSeq return very similar results when the full 
annotation was used, although JunctionSeq reported slightly weaker significance for the gene Slc15a1 
(see Table 2 and Table 3). 
When the transcript annotation was incomplete, DEXSeq fails to detect differential usage in 3 of the 
16 tests, one for Crem and two for Pde4b (at p-adjust < 0.01, see Table 3). JunctionSeq, on the other 
hand, still reports differential usage in all 16 tests (see Table 2). Furthermore, although the other five 
DEXSeq tests for the genes Crem and Pde4b are still statistically significant at p-adjust < 0.01, all of the 
reported p-values are several orders of magnitude weaker than those found in either the corresponding 
JunctionSeq analyses or the corresponding full-annotation DEXSeq analyses. 
Both the rat pineal gland and Toxoplasma gondii analyses lead us to the same conclusions: when the 
transcript annotation is complete and comprehensive, DEXSeq and JunctionSeq produce very similar 
results. However, when novel isoforms are involved, JunctionSeq provides superior performance. 
Other Advantages of JunctionSeq 
The improved visualization tools provided by JunctionSeq further increase its utility. In general, 
simply detecting the presence of AIR is insufficient; the investigator must also be able to determine 
precisely which isoforms or splice variants are responsible for the apparent differentials. In many cases 
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DEXSeq detects differentials in the same genes as JunctionSeq, however, even when manually examining 
the DEXSeq plots it is often impossible to identify the specific splice variants that are being differentially 
expressed, particularly when the relevant exons or splice junctions are unannotated. 
For example, in the Crem gene there are several clusters of small exonic regions (E009-E010, E013-
E015, E017-E021, see Figure 2) that are indistinguishable in the DEXSeq gene/transcript diagram (bottom 
of Figure 2b), but can be easily identified and matched to their corresponding isoforms in the JunctionSeq 
plot (bottom of Figure 2a and c), due to the nonlinear expansion of small features.  
Similarly, when novel isoforms are involved, it is often impossible to identify the relevant splicing 
variants in the DEXSeq plots, even when statistical significance is detected in the gene. This is because 
DEXSeq will often detect the indirect effects of alternative isoform usage, but the causal variants 
themselves will remain obscured. 
For example, in the incomplete-annotation analysis shown in Figure 4b, the first exon (E001) actually 
displays borderline statistical significance in the DEXSeq analysis (p-adjust =  0.016), due to the fact that 
this exon is not present in the (unobserved) alternative isoforms. However, even if this is considered 
significant it is impossible to identify the actual variants responsible for this effect, as they are not directly 
observable in the DEXSeq plots. The JunctionSeq plots, on the other hand, clearly show the source of the 
differential usage in the various “novel” splice junctions, most of which lead to the upstream alternative 
promoter site. 
If desired, JunctionSeq can (optionally) run pure exon-based analyses, reducing the number of 
comparisons. One of the major strengths of JunctionSeq is that it queries a broader array of regulatory 
phenomena, however this comes at the cost of additional comparisons, potentially reducing power. 
Running a purely exon-based analysis may provide superior results when working with a well-
characterized tissue on a comprehensively annotated genome. In fact, with a certain set of options 
(documented in the user manual), JunctionSeq will precisely reproduce a standard DEXSeq analysis while 
still providing the user with the enhanced visualization tools of JunctionSeq. To demonstrate the 
advantages of the JunctionSeq plotting engine we plotted identical analyses run by JunctionSeq and 
DEXSeq for a large and complex human gene using simulated data (see Supplemental figures 8-9). 
DISCUSSION 
JunctionSeq offers a powerful, flexible, statistically robust, and efficient solution for the 
identification, characterization, and interpretation of differential isoform regulation. The underlying 
methodology has a strong theoretical basis and is built upon established statistical methods that are 
already widely accepted by the community. It includes a number of powerful improvements that allow it 
to query a broader class of regulatory phenomena, including the differential regulation of novel splicing 
variants in the absence of an accurate and comprehensive transcript annotation.  
This is a critical addition to the community, as DEXSeq cannot consistently detect differentials in 
novel variants, and many popular tools such as Kallisto (19), eXpress (20), or RSEM (21) cannot assess 
novel variants at all. Furthermore, many transcript quantification tools seem to perform poorly when used 
with an incomplete transcript annotation (17). Although JunctionSeq may not necessarily provide uniform 
superiority over existing methods when the annotation is comprehensive, it provides a valuable tool for 
researchers studying esoteric tissues and/or less-common species. 
Another critical advantage of the JunctionSeq software toolset is its suite of powerful automated 
visualization and interpretation tools, which allow investigators to quickly and intuitively examine 
hundreds of genes. This assists investigators in identifying and characterizing genes of interest for further 
validation and study. 
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Example Interpretation 
For the purposes of demonstration we will examine a well-known AIR gene, Crem, in the rat pineal 
gland dataset. The mechanism behind the circadian alternative isoform regulation of the Crem gene is 
already well understood, and the patterns of expression of this gene’s various isoforms are well-
characterized (45,46,52). Briefly: an internal promoter is greatly upregulated at night, resulting in large 
quantities of a number of small transcripts collectively known as ICER. ICER is known to play a major 
role in the melatonin synthesis pathway (53). 
By default, JunctionSeq automatically generates gene profile plots for every gene that contains one or 
more differentially used exon or splice junction. Figure 2 (a, c, and d) displays a few of the available plots 
in the sham-surgery night/day experiment.  
As seen in the small rightmost panel of each JunctionSeq plot (i.e. the narrow panels labelled 
“GENE”), the Crem gene as a whole appears to display strong upregulation at night (~15,000 vs ~650 
read-pairs per sample). Looking at the gene profile plots we can see that this is not uniform across the 
gene: some of the exonic regions and splice junctions display strong upregulation at night while others do 
not. Exonic regions E009 through E021 all display strong differentials (>8x, see Figure 2c), but exonic 
regions E001 through E008 display consistently low counts at both day and night. The splice junction plot 
(see Figure 2d) shows similar results for the splice junction coverage. 
It may seem counterintuitive that the constant-expression exons (E001 through E008) are marked as 
statistically significant. This is because JunctionSeq (like DEXSeq) tests for differential usage, not 
differential expression. The expression of each sub-feature is compared with the expression of the gene as 
a whole (see the rightmost panel of each JunctionSeq plot in Figure 2). Since the gene as a whole has a 
strong differential, exonic regions and splice junctions that do not display such differentials are 
considered “differentially used” relative to the gene. 
Using the genome browser tracks produced in the QoRTs/JunctionSeq pipeline (Figure 3), we can 
examine the read coverage across the genome and over all known and novel splice junctions. These can 
be examined alongside external annotation tracks such as the RepeatMasker track or the UCSC-
maintained EST and mRNA databases. Visual examination alongside these tracks can be critical, as it can 
determine whether novel splice variants have been previously detected, or if apparent differentials might 
be the result of alignment artifacts or flaws in the annotation. 
Taken together, these visualizations lead towards a clear and obvious hypothesis: the full-length 
isoforms of the Crem gene display constant low-level expression at day and night, whereas the isoforms 
originating in the internal (“ICER”) promoter are greatly upregulated at night. This “hypothesis” matches 
the known behavior and function of this gene in the literature (45,46,52,53).  
Similar plots are available online for the Crem gene in the other three rat pineal gland experiments 
(See Supplemental Figures 5-7). 
The JunctionSeq R package 
We implemented the described method in a new Bioconductor package, JunctionSeq, written entirely 
in the R statistical programming language. 
The JunctionSeq analysis pipeline requires the QoRTs quality-control/data-processing software 
package (54) in order to generate the raw gene, exon, and splice junction counts. QoRTs is also used to 
create the multi-sample normalized-mean “wiggle” tracks for use with IGV or the UCSC genome 
browser. 
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The JunctionSeq package is extensively documented and includes a comprehensive walkthrough and 
example dataset, with line-by-line instructions describing the complete analysis pipeline. JunctionSeq will 
be included in Bioconductor release 3.3 (http://bioconductor.org/packages/JunctionSeq/), and is available 
now along with additional online help and documentation at the JunctionSeq webpage: 
http://hartleys.github.io/JunctionSeq/. 
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TABLES 
 
Table 1: JunctionSeq results. The numbers of genes found to exhibit significant differential exon or splice junction usage for the 
four rat pineal gland analyses at various p-value thresholds. A similar table for the DEXSeq analyses is available online. 
Adjusted 
p-value 
threshold 
In vivo In vitro 
Overlap, 
All Four Ctrl 
Day/Night 
Sham 
Day/Night 
Overlap, 
in vivo 
CN 
vs 
NE 
CN 
vs 
DBcAMP 
Overlap, 
in vitro 
0.01 447 320 168 144 195 90 42 
0.001 300 202 116 89 127 61 28 
0.0001 227 151 94 67 91 48 18 
0.00001 182 119 79 51 74 38 15 
0.000001 151 98 61 43 65 34 14 
 
 
Table 2: JunctionSeq gene-level adjusted p-values for 4 known-AIR genes in the rat pineal gland, both with and without a 
complete isoform annotation. The left 4 columns display the results from a normal analysis, the right 4 columns display the 
results from an analysis in which all but one isoform was removed from the annotation for each gene, simulating a scenario in 
which the gene is poorly studied and the annotation incomplete. *Note: since the Slc15a1 gene actually only has one known 
transcript, the “full” and “incomplete” annotation analyses for this gene are equivalent, differing only slightly due to minor 
analysis-wide differences in the dispersion estimation and multiplicity correction. 
Gene  
Symbol 
Full Annotation Incomplete Annotation (1 “known” isoform) 
Ctrl 
Day/Night 
Sham 
Day/Night 
CN 
vs 
NE 
CN 
vs 
DBcAMP 
Ctrl 
Day/Night 
Sham 
Day/Night 
CN 
vs 
NE 
CN 
vs 
DBcAMP 
Atp7b <1e-8 <1e-8 <1e-8 <1e-8 <1e-8 <1e-8 <1e-8 <1e-8 
Crem <1e-8 <1e-8 <1e-8 <1e-8 <1e-8 <1e-8 <1e-8 <1e-8 
Pde4b <1e-8 <1e-8 <1e-8 <1e-8 <1e-8 <1e-8 <1e-8 2.8e-7 
Slc15a1 <1e-8 <1e-8 0.0034 0.0015 <1e-8* <1e-8* 0.0034* 0.0016* 
 
Table 3: DEXSeq gene-level adjusted p-values for 4 known-AIR genes in the rat pineal gland, both with and without a complete 
isoform annotation. See Table 2. Note that without the complete annotation, several tests do not show significant differential 
usage or have much less significant p-values. 
Gene 
Symbol 
Full Annotation Incomplete Annotation (1 “known” isoform) 
Ctrl 
Day/Night 
Sham 
Day/Night 
CN 
vs 
NE 
CN 
vs 
DBcAMP 
Ctrl 
Day/Night 
Sham 
Day/Night 
CN 
vs 
NE 
CN 
vs 
DBcAMP 
Atp7b <1e-8 <1e-8 <1e-8 <1e-8 <1e-8 <1e-8 <1e-8 <1e-8 
Crem  <1e-8 <1e-8 <1e-8 <1e-8 1.2e-5 0.0357 6.5e-6 9.3e-5 
Pde4b <1e-8 <1e-8 <1e-8 <1e-8 1.2e-4 0.0041 1.0 1.0 
Slc15a1 <1e-8 <1e-8 3.3e-5 2.7e-5 <1e-8* <1e-8* 3.2e-5* 3.0e-5* 
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FIGURES 
Figure 1: Gene profile plots from (a) JunctionSeq and (b) DEXSeq for the TGGT1_207900 gene, in the 8-hour-induced vs un-
induced Toxoplasma gondii experiment. The large central plotting panel of (a) and (b) displays the estimates for the mean 
normalized read counts for each exon or splice junction for the 8-hour-induced (red) or uninduced (blue) sample groups. The 
narrow panel on the right in (a) displays the gene-level mean normalized read counts. In each plot a gene diagram is drawn 
beneath the main plotting panels, showing the location and layout of the gene. Statistically significant (p-adjust < 0.01) exons or 
junctions are drawn with pink, and features that had counts that were too low to test are drawn in light gray (or they would be, if 
there were any such features). Known splice junctions are drawn with solid lines and unannotated splice junctions are drawn with 
dashed lines. Note in the JunctionSeq plot the first two splice junctions are strongly and significantly differentially used (in 
opposing directions). This effect was confirmed in a previous study via qRT-PCR (34). Also note that differential usage is not 
apparent in the DEXSeq plot, as the differentially used features are unannotated. Similar plots for the other two Toxoplasma 
gondii experiments can be found online, and show similar results (see supplemental figs. 1-2).  
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Figure 2: Day/Night gene profile plots for the Crem gene in the rat pineal gland, sham-surgery group. Plots (a), (c), and (d) were 
produced by JunctionSeq, and (b) was produced by an equivalent analysis using DEXSeq. The full standard JunctionSeq gene 
profile plot (a) includes both exon and splice junction information. The equivalent DEXSeq plot (b) only displays exon 
information. Optionally, JunctionSeq can produce similar exon profile plots (c), or plots displaying only splice-junction 
information (d). Beneath the plotting regions in each figure a gene diagram displays the features’ positions on the genomic scale 
(note that small features are expanded for readability in the JunctionSeq versions). Novel junction loci are drawn using dashed 
lines. In the upper plots (a and b), all known transcripts are displayed beneath the main plotting area. Similar plots are available 
online for the control day/night comparison, as well as the two treated-vs-untreated comparisons (see Supplemental Figures 5-7). 
18 
 
Figure 3: Genome-wide Browser tracks produced in the QoRTs/JunctionSeq pipeline. The above screenshot displays much of the 
same information found in Figure 2, except using the UCSC genome browser. The top track displays the ensembl gene 
annotation. The second track displays the statistically significant features, with the adjusted p-value included in parentheses. The 
next track is a “wiggle” track that displays coverage over both the forward and reverse strand (above and below the x-axis, 
respectively), in red and blue for day and night, respectively (overlap is colored black). The next two tracks display all exons and 
splice junctions, respectively, that were tested for DU by JunctionSeq. The day/night normalized mean expression values from 
Figure 2 are included in parentheses. The final track is from RepeatMasker, and displays regions with repeating or low-
complexity elements. Using these tracks together can be vital for the purposes of interpretation and validation. 
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Figure 4: Day/Night gene profile plots for the Crem gene, created by JunctionSeq (a) and DEXSeq (b), both using an incomplete 
transcript annotation. These plots are equivalent to Figure 2 (a) and (b), except that all the transcripts except one (transcript 
ENSRNOT00000074146) were removed from the annotation prior to analysis. Without the a priori knowledge of the missing 
transcripts, DEXSeq cannot reliably detect differential usage. Note that the “novel” junction N010 is actually known junction 
J028 from Figure 2. Similarly, N014 is J032 and N015 is J035. The other novel junctions are not present even in the full 
annotation. It should be noted that exon E001 shows borderline statistical significance in the DEXSeq plot (p-adjust = 0.016). 
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1 Supplementary Results 
Supplemental fig. 1: Gene profile plots, 4-hr vs control. 
 
Displays the same information as figure 5 from the main text, except for the uninduced vs 4-hour-induced Toxoplasma gondii 
experiment. 
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Supplemental fig. 2: Gene profile plots, 24-hr vs control. 
 
Displays the same information as figure 5 from the main text, except for the uninduced vs 24-hour-induced Toxoplasma gondii 
experiment. 
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Supplemental fig. 3: JunctionSeq Results Venn diagrams.  
 
Venn diagrams describing the overlap in the genes found to possess splice junctions that display statistically significant 
(adjusted-p < 0.000001) differential usage in the four rat pineal analyses.  
Supplemental fig. 4: DEXSeq results Venn diagrams.  
 
This Venn diagram, similar to the previous figure, displays the overlap between the results from the various in vivo and in vitro 
analyses performed by DEXSeq. As before, each cell displays the number of genes shared between the various analyses at 
adjusted-p < 0.000001.  
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Supplemental Table 1: DEXSeq results.  
Adjusted 
p-value 
threshold 
In vivo In vitro 
Overlap, 
All Four Ctrl 
Day/Night 
Sham 
Day/Night 
Overlap, 
in vivo 
CN 
vs 
NE 
CN 
vs 
DBcAMP 
Overlap, 
in vitro 
0.01 289 240 110 121 192 86 28 
0.001 189 152 85 90 129 67 20 
0.0001 147 106 69 61 87 42 17 
0.00001 112 82 56 44 67 32 10 
0.000001 92 76 49 40 61 27 10 
Similar to Table 1 from the main text. Lists the numbers of genes found by DEXSeq to exhibit significant differential exon usage 
for the five rat pineal gland analyses. 
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Supplemental fig. 5: Gene profile plots for Crem, sham night/day. 
 
Comparison of gene profile plots generated by DEXSeq (a) and JunctionSeq (b) for the Crem gene in the sham day/night rat 
pineal gland experiment. 
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Supplemental fig. 6: Gene profile plots for Crem, untreated vs norepinephrine. 
 
Comparison of gene profile plots generated by JunctionSeq (a) and DEXSeq (b) for the Crem gene in the untreated control vs 
DBcAMP-treated rat pineal gland experiment. 
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Supplemental fig. 7: Gene profile plots for Crem, untreated vs DBcAMP. 
 
Comparison of gene profile plots generated by JunctionSeq (a) and DEXSeq (b) for the Crem gene in the untreated control vs NE-
treated rat pineal gland experiment. 
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Supplemental fig. 8: DEXSeq Gene profile plot, example human gene (simulated data). 
 
30 
 
The above plot shows a DEXSeq plot for a moderately-complex human gene and a simulated dataset. Note that it is completely impossible to 
distinguish many exonic and splicing variants in the gene diagram, because many of the features are less than a pixel wide even at high 
resolution. 
 
31 
 
Supplemental fig. 9: JunctionSeq Gene profile plot, example human gene (simulated data). 
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Using a specific set of optional parameters, JunctionSeq will reproduce a standard DEXSeq analysis, and then output plots using its own 
improved visualization engine. The above plot shows a JunctionSeq plot replicating the analysis that produced Supplemental fig. 8for a 
moderately-complex human gene and a simulated dataset. Note the various improvements in the lower plot produced by JunctionSeq. For 
example: exonic labels are shrunk and drawn at an angle, exonic and intronic regions are rescaled to improve readability, the overall gene-level 
expression is shown on the right, nested splice junctions are included, exon fragments are separated by dotted lines instead of solid ones, and 
exonic regions that do not satisfy the hypothesis test inclusion thresholds are drawn with a lighter gray. 
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2 Statistical Methodology 
2.1 Model framework 
Each exonic region or splice junction locus (or “feature”) is fitted to a separate model. All terms from 
here forward are relative to a specific feature 𝑗, which is an exonic region or splice junction locus on gene 
𝑔. Let there be 𝑛 biological replicates (or “samples”). 
For this feature 𝑗, we define two “counting bins”: 𝒚�⃗ 1 = (𝑦11,𝑦12, … ,𝑦1𝑛) and 𝒚�⃗ 0 =(𝑦01,𝑦02, … ,𝑦0𝑛). 
The counts 𝑦1𝑖 are defined as the number of reads (or read-pairs) in sample 𝑖 that cover the feature 𝑗. 
That is, the number of reads or read-pairs that intersect with the exonic region (if 𝑗 is an exon) or align 
over the splice junction (if 𝑗 is a splice junction). The counts 𝑦0𝑖 are defined as the number of reads (or 
read-pairs) that intersect with the gene 𝑔, but that do not cover the specific feature 𝑗. The gene-level 
counts are calculated using the standard HTSeq-based method used for DESeq2/edgeR differential gene 
expression. 
Note: for the exon/junction counts, only read-pairs that actually align to the junction or exon itself are 
counted, read-pairs that only flank a feature are NOT counted towards that feature. 
In the framework used by DEXSeq 1.12.2 (which, it should be noted, differs slightly from the original 
framework used by some earlier versions and presented in the DEXSeq methods paper) the feature counts 
(𝑦1𝑖) are compared with the sum of all other feature counts belonging to the same gene. This means that 
some reads may be counted more than once if they span multiple features. When reads are relatively short 
(as was typical when DEXSeq was first introduced) this effect is minimal, but it becomes progressively 
less precise for longer reads. While, in theory, the methods used by DEXSeq should be robust against this 
issue, under certain circumstances it can result in unexpected artifacts. For example, if a gene has a large 
number of features in a very small genomic area (for example, if an exon has numerous alternative 
donor/acceptor sites), then reads covering that region may be disproportionately over-weighted, altering 
the relative fold change estimates by warping the linear contrasts. 
Under our framework, no read-pair is ever counted more than once in each model. 
These counts can be generated via QoRTs, a freely-available and open-source software package that 
provides both QC and data processing for RNA-Seq datasets (54).  
The gene and exon counts could theoretically be generated by HTSeq, but there is currently no 
HTSeq-based method of generating the JunctionSeq input files which also include counts for known and 
novel splice junctions. 
2.2 Novel splice junctions 
In addition to the known splice junctions provided by a transcript annotation, novel splice junctions 
detected by the alignment software can be added to the analysis. These unannotated junctions can be 
selected for inclusion in the analysis if they had at least one endpoint within the span of a single gene and 
if they had a mean-normalized read-pair coverage (across all conditions) of greater than an assigned 
threshold (the default is 6 read-pairs per biological replicate).  
2.3 Statistical Model 
As in DEXSeq, we assume that the count 𝑦𝑏𝑖 is a realization of a negative-binomial random variable 
𝑌𝑏𝑖: 
34 
 
𝑌𝑏𝑖~ 𝑁𝑁�𝑚𝑚𝑚𝑛 = 𝑠𝑖𝜇𝑏𝑖,𝑑𝑖𝑠𝑑𝑚𝑑𝑠𝑖𝑑𝑛 =  𝛼𝑗� 
Where 𝛼𝑗 is the dispersion parameter for feature 𝑗, 𝑠𝑖 is the normalization size factor for sample 𝑖, and 
𝜇𝑏𝑖 is the normalized mean for sample 𝑖 and counting-bin 𝑏. (Remember that (𝑏 = 1) refers to the feature 
(ie. exon/splice-junction) counts and (𝑏 = 0) refers to the gene counts minus the feature counts.) 
The normalization size factors 𝑠𝑖 are estimated using the "geometric" normalization method, which is 
the default method used by DESeq, DESeq2, DEXSeq, and CuffDiff (14,22,55,56). By default these 
normalizations are performed based on the gene-level counts. 
2.4 Dispersion estimation 
In many high-throughput sequencing experiments there are too few replicates to directly estimate the 
locus-specific dispersion term 𝛼𝑗 for each feature 𝑗. This problem is well-characterized, and a number of 
different solutions have been proposed, the vast majority of which involve sharing information between 
loci across the genome (55,57). JunctionSeq uses the same method used by the DESeq2 package and by 
the more recent releases of the DEXSeq package. This method is described in detail elsewhere (23). 
Briefly: individual-feature estimates of dispersion are generated via a Cox-Reid-based method. Then, 
a parametric model is fitted to these dispersions: 
𝛼(𝜇) = 𝛼1
𝜇
+ 𝛼0 
Where 𝜇 is the “base mean”, or the sum of the normalized counts across the feature. The final 
dispersions are based on the maximum a posteriori (MAP) estimator, which combines information from 
the feature-specific and fitted dispersion estimates. The JunctionSeq R package also implements a number 
of other optional methods for estimating the dispersion (see Additional File 1). 
2.5 Hypothesis tests for differential usage (DU) 
The hypothesis test is performed using the same DESeq2-based methods used in DEXSeq v1.14.0, 
which are described in detail elsewhere (23). Note that the methods used in (23) include numerous 
improvements on the methods originally described in the DEXSeq methodology paper (22). 
Briefly: two models are fitted to the mean 𝜇𝑏𝑖. First, the reduced (null hypothesis) model: log(𝜇𝑏𝑖) = 𝛽 + 𝛽𝑏𝐵 + 𝛽𝑖𝑆 
And then the alternative model: log(𝜇𝑏𝑖) = 𝛽 + 𝛽𝑏𝐵 + 𝛽𝑖𝑆 + 𝛽𝜌𝑖𝑏𝐶𝐵  
Where 𝜌𝑖 is the experimental condition value for sample 𝑖. 
Note that the experimental-condition/counting-bin interaction term (𝛽𝜌𝑖𝑏
𝐶𝐵 ) is included, but the 
experimental-condition main-effects term (𝛽𝜌𝑖
𝐶 ) is absent. This term can be omitted because JunctionSeq is 
not designed to detect or assess gene-level differential expression. Thus there are two components that 
can be treated as "noise": variation in junction-level expression and variation in gene-level expression. As 
proposed by Anders et. al. (22), we use a main-effects term for the sample ID (𝛽𝑖𝑆), which subsumes the 
condition main-effect term. This subsumes both differential and random variation (noise) in the gene-
level expression, improving the power for detecting differential interaction between the count-bin term 
and the experimental-condition term. 
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2.6 Parameter Estimation: 
While the statistical model described above is robust, efficient, and powerful, it lacks main effect 
terms and thus cannot be effectively used to estimate the size of the differential effect. 
For the purposes of estimating the effect sizes and expression levels we create a separate set of 
generalized linear models for each feature. In this we diverge substantially from the current DEXSeq 
methods.  
The mean 𝜇𝑏𝑖 is modeled as: log(𝜇𝑏𝑖) = 𝛽 + 𝛽𝑏𝐵 + 𝛽𝜌𝑖𝐶 + 𝛽𝜌𝑖𝑏𝐶𝐵  
This model is used to calculate the parameter estimates ?̂?, ?̂?𝑏𝐵, ?̂?𝜌𝑖
𝐶 , and ?̂?𝜌𝑖𝑏
𝐶𝐵 , which are then used to 
calculate mean normalized coverage estimates ?̂?𝜌 for each condition value 𝜌. Using linear contrasts, 
relative expression estimates can also be calculated for each junction locus and each condition value, 
producing an estimate of relative fold-change. This differs from the DEXSeq methodology, which fits one 
large model to the full set of features belonging to the given gene. 
2.7 Multivariate Models: 
If needed, additional covariates can be integrated into the generalized linear models. If we define 𝜏𝑖 as 
the covariate category for sample 𝑖, then we can define the hypothesis test reduced model as: log(𝜇𝑏𝑖) = 𝛽 + 𝛽𝑏𝐵 + 𝛽𝑖𝑆 + 𝛽𝜏𝑖𝑏𝑇𝐵 
And the alternative hypothesis model: log(𝜇𝑏𝑖) = 𝛽 + 𝛽𝑏𝐵 + 𝛽𝑖𝑆 + 𝛽𝜏𝑖𝑏𝑇𝐵 + 𝛽𝜌𝑖𝑏𝐶𝐵  
Like the main effects term for the condition variable, the main effects term for the confounding 
variable is absent from both of the models used in the hypothesis test. This main effects term is subsumed 
into the sample-ID term 𝛽𝑖𝑆. 
The parameter-estimation model can be extended similarly:  log(𝜇𝑏𝑖) = 𝛽 +  𝛽𝑏𝐵 + 𝛽𝜌𝑖𝐶 + 𝛽𝜏𝑖𝑇 + 𝛽𝜏𝑖𝑏𝑇𝐵 + 𝛽𝜌𝑖𝑏𝐶𝐵  
In general the expression estimates are generated by averaging over confounding variable status. 
Optionally the expression estimates could be generated for each confounder status separately. 
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3 Test Dataset Data Processing and Methods 
3.1 Application 1: Toxoplasma gondii 
Our first test dataset originated from a previous study in which alternative splicing was detected and 
validated in Toxoplasma gondii between control samples and samples in which overexpression of the 
TgSR3 gene was induced (8). There were four sample groups of 3 biological replicates each: untreated; 
induced, 4 hours; induced, 8 hours; and induced, 24 hours. The dataset is available on the NCBI short 
read archive (SRA), accession number PRJNA252680.  
Reads were realigned with RNA-STAR (9) to the ToxoDB v25 Toxoplasma gondii GT1 genome build 
and annotation (10). The dataset was processed via the QoRTs (1) data processing package and analyzed 
with JunctionSeq. Unlike with the previous study’s analysis, a full CuffLinks transcript assembly was 
unnecessary as JunctionSeq can test novel splice junctions of known genes. We ran three analyses 
comparing each of the three induced groups to the untreated group. 
3.2 Application 2: Circadian Rhythms in the Rat Pineal Gland 
Our second test dataset consisted of 7 sample groups, 4 taken from live Rattus norvegicus pineal 
glands and 3 taken from rat pineal glands in organ culture, with 3 biological replicates each (21 biological 
replicate, total). The dataset is available online on the NCBI short read archive (SRA), accession number 
PRJNA267246. The surgical methods, sample collection, and sequencing is described in detail elsewhere 
(11). Briefly: the 12 in vivo samples were taken from no-surgery (Ctrl) and sham-surgery (Sham) rats at 
two time points: night and day. The 9 in vitro samples consisted of pineal glands in organ culture treated 
with norepinephrine (NE) or dibutyryl cyclic AMP (DBcAMP, an analogue of the second messenger, 
cAMP), as well as untreated controls (CN). 
The 21 samples were aligned to the rn6 rat genome build using the RNA-STAR aligner (9) with the 
ensembl transcript annotation (release 80). Gene, exon, and splice-junction read-pair counts were then 
generated by the QoRTs data processing utility (1), adding novel splice junctions if they could be matched 
to a single known gene and if their mean normalized coverage across all samples exceeded 3. The five 
analyses were then carried out using JunctionSeq and DEXSeq using the standard developer-
recommended options. The adjusted-p-value threshold for all plots was set to p-adjust < 0.01, which is the 
default for JunctionSeq. 
3.2.1 Incomplete Annotation 
To demonstrate JunctionSeq’s ability to detect differential usage in novel splice junctions even with 
an incomplete transcript assembly, we performed a second set of analyses with a reduced annotation. For 
each of the four known AIR genes (Crem, Pde4b, Slc15a1, and Atp7b), we manually removed all but one 
transcript from the ensembl annotation GTF and then re-ran the analyses. Since the gene Slc15a1 only has 
one known transcript, it was not altered in this analysis.  
In general it was not possible to uniquely identify the dominant isoform from each gene. When 
selecting which isoform to leave in the annotation, we chose one of the most likely dominant isoforms 
based on the exon and junction coverages found by JunctionSeq. In truth it does not affect the validity of 
the experiment, since in practice the annotated isoform may be any one of the true isoforms (or in some 
cases even be a false isoform that does not actually exist). See Supplemental Table 2 for a full listing of 
the isoforms used in the partial annotation analysis. 
All genes/transcripts other than the ones belonging to the four known AIR genes were included in the 
analysis as normal. They had to be included because JunctionSeq shares information across genes in order 
to estimate the size factors and biological dispersion. 
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Supplemental Table 2: Genes and transcripts selected for use in the “incomplete annotation” analysis. 
Gene 
Symbol 
# Known 
Transcripts 
Gene Ensembl ID Transcript used in the 
“incomplete” annotation 
Atp7b 2 ENSRNOG00000012878 ENSRNOT00000089265 
Crem 7 ENSRNOG00000014900 ENSRNOT00000074146 
Pde4b 3 ENSRNOG00000005905 ENSRNOT00000007738 
Slc15a1 1 ENSRNOG00000011598 ENSRNOT00000015890 
It should be noted that the adjusted-p-values listed in the “full” and the “incomplete” analyses for the 
gene Slc15a1 were slightly different, despite the fact that the gene annotations were unchanged for this 
gene. This was due to (very slight) analysis-wide differences in the two sets of analyses. JunctionSeq and 
DEXSeq both share information between genes to calculate size factors and dispersion estimates. 
Furthermore, the FDR-based Benjamini-Hochberg multiplicity correction procedure causes the adjusted-
p-values of each test to depend on the other p-values in each set (12). Thus, changes to one gene can 
(usually only slightly) change the results for the other genes. 
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